Myriad’s True Value

Some interesting points raised in a NY Times editorial yesterday regarding Myriad’s true underlying value being in its database of mutations. In a paper referenced by the editorial the authors describe Myriad’s database of BRCA1/2 mutations and the value...

Reporting rates for clinical trials

Unmasking ‘Invisible’ Drug Trials – ScienceInsider. Do drug companies and other commercial entities have an obligation to report the results of the clinical trials they have sponsored? Interesting question, that. Most trials for novel therapeutics...